# Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

> **NCT03093688** · PHASE1,PHASE2 · RECRUITING · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 40 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Small Cell Lung Cancer
- Pancreas Cancer
- Hepatocellular Carcinoma
- Gastric Cancer
- Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** Infusion of iNKT cells and CD8+T cells

## Key facts

- **NCT ID:** NCT03093688
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-03-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03093688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03093688, "Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03093688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*